1 Follower


Dymicron, Inc. is a privately held, innovative medical technology company that is advancing a new generation of musculoskeletal implant devices made from polycrystalline diamond (PCD) — one of the strongest substances known to man, and a material for which Dymicron has exclusive patented use for all medical applications in the human body.


Add photos to showcase Dymicron’s culture


Add Dymicron’s values

Insider experiences

Share your experience of working at Dymicron

Alan S. Layton
Chairman of the Board and CEO
Jeff Bennett
President and Chief Operating Officer
Gunther Peeters
SVP, Commercial Operations

Add your teams to show how people work together at Dymicron

Add jobs to your org chart to show candidates who they’ll work with

Team announcement

Dr. Armen Katchatryan appointed to Dymicron Board of Directors

Dr. Armen Katchatryan appointed to Dymicron Board of Directors

Medical device company Dymicron has announced the appointment of Dr. Armen Katchatryan to its Board of Directors. "We are delighted to welcome Dr. Khachatryan to Dymicron's Board," said Dymicron Chairman and CEO Alan Layton. "Dr. Khachatryan's highly accomplished track record and vast experience with cervical arthroplasty will be tremendously helpful to our company as we prepare for FDA clinical trials in the US and commercialization in select countries outside the US with our CE Mark." Dr. Katchatryan is a board-certified orthopedic surgeon, with extensive experience in minimally invasive procedures, motion preservation technology, artificial disc replacement and non-fusion technologies. He has been a clinical investigator in a range of FDA clinical trials and has helped to train hundreds of surgeons advanced spinal surgery techniques. "I am excited and honored to join the Dymicron team at this important juncture in the company's development,” said Dr. Khachatryan. “I believe the natural constrained motion characteristics of the distinctive Tri-Lobe design, combined with the unrivaled wear properties of the Polycrystalline Diamond material, has the real potential to position the Triadyme-C as an emerging leader in next-generation cervical arthroplasty devices."

Team announcement

Dymicron Adds Industry Veteran Ted Bird to Leadership Team

Dymicron Adds Industry Veteran Ted Bird to Leadership Team

Medical device manufacturer Dymicron has announced the appointment of Ted Bird as Executive Vice President, Corporate Development, and Chief Strategy Officer. In the role, Bird will oversee Dymicron's corporate strategy, business & market development, investor relations, marketing, and commercialization. He will be based out of Charleston, SC, and report directly to company President and Chief Operating Officer at Dymicron Jeff Bennett. Bird brings over 35 years of global commercial experience in the medical device space to the team at Dymicron. He most recently was the Chief Commercial Officer at Titan Spine and prior to that served in leadership positions at Johnson & Johnson as well as Medtronic. "I am excited to join the Dymicron team to help introduce an extraordinary next-generation artificial cervical disc to the global spine community. This product is unique in the market due to its innovative composition, which utilizes a proprietary polycrystalline diamond material, and its patented Tri-Lobe articulating design. The exceptional durability of polycrystalline diamond virtually eliminates the risks of artificial disc wear debris for the lifetime of the patient. At the same time, the Tri-Lobe design mimics the natural kinematics and motion of a normal disc." said Bird Bird graduated from Brown University and outside of work enjoys spending time with his family, traveling and sailing.

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.